{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:38:47Z","timestamp":1793911127581,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400315"],"award-info":[{"award-number":["82400315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016072","name":"Postdoctoral Scientific Research Development Fund of Heilongjiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["PL2024H033"],"award-info":[{"award-number":["PL2024H033"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.yexcr.2026.115048","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:36:48Z","timestamp":1777390608000},"page":"115048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["ALPK1 promotes cardiomyocyte hypertrophy by activating NF-\u03baB\/NLRP3 inflammasome-mediated pyroptosis"],"prefix":"10.1016","volume":"460","author":[{"given":"Xiaomi","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8594-0510","authenticated-orcid":false,"given":"Zeyao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-6802","authenticated-orcid":false,"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yexcr.2026.115048_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115048_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115048_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jjcc.2023.10.009","article-title":"Heart failure management guidelines: new recommendations and implementation","volume":"83","author":"Heidenreich","year":"2024","journal-title":"J. Cardiol."},{"issue":"18","key":"10.1016\/j.yexcr.2026.115048_bib4","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2026.115048_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131400","article-title":"Associations between systemic immunity-inflammation index and heart failure: evidence from the NHANES 1999-2018","volume":"395","author":"Zheng","year":"2024","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2295384","article-title":"Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-Heptose release and ALPK1\/TIFA axis activation","volume":"16","author":"Martin-Gallausiaux","year":"2024","journal-title":"Gut Microbes"},{"issue":"7721","key":"10.1016\/j.yexcr.2026.115048_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-018-0433-3","article-title":"Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-Heptose","volume":"561","author":"Zhou","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3892\/br.2013.190","article-title":"Association of genetic variants of the \u03b1-kinase 1 gene with myocardial infarction in community-dwelling individuals","volume":"2","author":"Fujimaki","year":"2014","journal-title":"Biomedical reports"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115048_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3892\/br.2015.440","article-title":"Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study","volume":"3","author":"Yamada","year":"2015","journal-title":"Biomedical reports"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115048_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/br.2015.439","article-title":"Association of genetic variants of the \u03b1-kinase 1 gene with type 2 diabetes mellitus in a longitudinal population-based genetic epidemiological study","volume":"3","author":"Yamada","year":"2015","journal-title":"Biomedical reports"},{"key":"10.1016\/j.yexcr.2026.115048_bib11","article-title":"ALPK1 phosphorylates myosin IIA modulating TNF-\u03b1 trafficking in gout flares","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.yexcr.2026.115048_bib12","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/jbmr.4669","article-title":"ALPK1 accelerates the pathogenesis of osteoarthritis by activating NLRP3 signaling","volume":"37","author":"Liu","year":"2022","journal-title":"J. Bone Miner. Res.: the official journal of the American Society for Bone and Mineral Research"},{"issue":"12","key":"10.1016\/j.yexcr.2026.115048_bib13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/00220345221100179","article-title":"ALPK1 aggravates TMJOA cartilage degradation via NF-\u03baB and ERK1\/2 signaling","volume":"101","author":"Liu","year":"2022","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.yexcr.2026.115048_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705751","article-title":"Alpk1 sensitizes pancreatic beta cells to cytokine-induced apoptosis via upregulating TNF-\u03b1 signaling pathway","volume":"12","author":"Ding","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40659-023-00416-7","article-title":"Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway","volume":"56","author":"Cui","year":"2023","journal-title":"Biol. Res."},{"issue":"18","key":"10.1016\/j.yexcr.2026.115048_bib16","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.3390\/cancers14184390","article-title":"Systematic review of the role of alpha-protein kinase 1 in cancer and cancer-related inflammatory diseases","volume":"14","author":"Ko","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.yexcr.2026.115048_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacbts.2023.05.008","article-title":"TAK1 activation by NLRP3 deficiency confers cardioprotection against pressure overload-induced cardiomyocyte pyroptosis and hypertrophy, JACC","volume":"8","author":"Li","year":"2023","journal-title":"Basic to translational science"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41420-021-00434-y","article-title":"NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin","volume":"7","author":"Yue","year":"2021","journal-title":"Cell Death Discov."},{"issue":"21","key":"10.1016\/j.yexcr.2026.115048_bib19","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.3390\/cells11213336","article-title":"Angiotensin II-Induced signal transduction mechanisms for cardiac hypertrophy","volume":"11","author":"Bhullar","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/iep.12427","article-title":"NLRC5 enhances autophagy via inactivation of AKT\/mTOR pathway and ameliorates cardiac hypertrophy","volume":"103","author":"Ba","year":"2022","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.yexcr.2026.115048_bib21","article-title":"Pyroptosis: role and mechanisms in cardiovascular disease","volume":"9","author":"Chen","year":"2022","journal-title":"Frontiers in cardiovascular medicine"},{"key":"10.1016\/j.yexcr.2026.115048_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9743280","article-title":"NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia\/reperfusion injury in diabetic rats","volume":"2017","author":"Qiu","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115048_bib23","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11010-023-04812-1","article-title":"Mitochondria and NLRP3 inflammasome in cardiac hypertrophy","volume":"479","author":"Yan","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.062","article-title":"Innate immunity and cardiomyocytes in ischemic heart disease","volume":"100","author":"Lin","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.yexcr.2026.115048_bib25","article-title":"Toll-like receptors in cardiac hypertrophy","volume":"10","author":"Zhang","year":"2023","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.32614","article-title":"Alpha-kinase 1 (ALPK1) agonist DF-006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B","volume":"77","author":"Xu","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.yexcr.2026.115048_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12371","article-title":"Engineered small extracellular vesicle-mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy","volume":"12","author":"Kang","year":"2023","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.yexcr.2026.115048_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","article-title":"Mechanisms for the transition from physiological to pathological cardiac hypertrophy","volume":"98","author":"Oldfield","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115048_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.870924","article-title":"Cardiac remodeling in heart failure: role of pyroptosis and its therapeutic implications","volume":"9","author":"Chai","year":"2022","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"9","key":"10.1016\/j.yexcr.2026.115048_bib30","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.yexcr.2026.115048_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1377359","article-title":"The role of pyroptosis in heart failure and related traditional Chinese medicine treatments","volume":"15","author":"Qin","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.yexcr.2026.115048_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115048_bib33","article-title":"Inhibition of Sema4D attenuates pressure overload-induced pathological myocardial hypertrophy via the MAPK\/NF-\u03baB\/NLRP3 pathways","volume":"1870","author":"Wu","year":"2024","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115048_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Walle","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115048_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2026.115048_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108046","article-title":"Selective inhibition of NLRP3 inflammasome reverses pressure overload-induced pathological cardiac remodeling by attenuating hypertrophy, fibrosis, and inflammation","volume":"99","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2026.115048_bib37","article-title":"The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mouse model","volume":"181","author":"Li","year":"2024","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115048_bib38","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","article-title":"Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950","volume":"73","author":"Corcoran","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yexcr.2026.115048_bib39","article-title":"MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:33:39Z","timestamp":1783110819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0014482726001655"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115048","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALPK1 promotes cardiomyocyte hypertrophy by activating NF-\u03baB\/NLRP3 inflammasome-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115048"}}